SCHEMBL7216425

SCHEMBL7216425

c1ccc(Nc2ncnc3[nH]c4ccccc4c23)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 1.00
ABL1 P00519 4/20 0.72
ABL2 P42684 2/20 0.72
TNNI3K Q59H18 2/20 0.62
BRAF P15056 1/20 0.62
PRKCA P17252 2/20 0.61
DAPK3 O43293 1/20 0.54
MAP4K4 O95819 1/20 0.54
ERBB2 P04626 1/20 0.54
PIM1 P11309 1/20 0.54
PRKACA P17612 1/20 0.54
LTK P29376 1/20 0.54
MAPK8 P45983 1/20 0.54
CSNK1A1 P48729 1/20 0.54
RPS6KA3 P51812 1/20 0.54
LIMK1 P53667 1/20 0.54
MAP2K1 Q02750 1/20 0.54
ACVR1 Q04771 1/20 0.54
TYRO3 Q06418 1/20 0.54
MAP4K2 Q12851 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7497652 0.84 EGFR (1.00) EGFRABL1ABL2TNNI3KBRAF
SCHEMBL7222290 0.84 EGFR (1.00) EGFRABL1ABL2TNNI3KBRAF
Hydrochloric Acid SCHEMBL7499723 0.83 EGFR (0.97) EGFRABL1ABL2TNNI3KBRAF
Hydrochloric Acid SCHEMBL7217999 0.83 EGFR (0.97) EGFRABL1ABL2TNNI3KBRAF
SCHEMBL7215763 0.78 EGFR (0.97) EGFRABL1DAPK3MAP4K4ERBB2
SCHEMBL6882539 0.78 TNNI3K (1.00) EGFRABL1ABL2TNNI3KBRAF
Hydrochloric Acid SCHEMBL7215860 0.77 EGFR (1.00) EGFRABL1DAPK3MAP4K4ERBB2
SCHEMBL2461344 0.76 EGFR (1.00) EGFRABL1ABL2PRKCA
SCHEMBL30159366 0.74 LIMK1 (0.59) EGFRABL1ABL2ERBB2LIMK1
SCHEMBL3473013 0.74 LIMK1 (0.59) EGFRABL1ABL2ERBB2LIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596726-B1 Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme WARNER LAMBERT COMPANY 2003-07-22 US disclosed
EP-0741711-A1 TRICYCLIC COMPOUNDS CAPABLE OF INHIBITING TYROSINE KINASES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR FAMILY WARNER-LAMBERT COMPANY (US) 1996-11-13 EP disclosed
WO-1995019970-A1 TRICYCLIC COMPOUNDS CAPABLE OF INHIBITING TYROSINE KINASES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR FAMILY WARNER-LAMBERT COMPANY (US) 1995-07-27 WO disclosed